Cann Group Limited (ASX:CAN)

Market Cap	9.77M
Revenue (ttm)	15.51M
Net Income (ttm)	-47.60M
Shares Out	651.31M
EPS (ttm)	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,608,169
Average Volume	893,668
Open	0.0160
Previous Close	0.0150
Day's Range	0.0140 - 0.0160
52-Week Range	0.0100 - 0.1277
Beta	1.04
RSI	54.11
Earnings Date	Aug 28, 2025

About Accolade

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe. It also licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CAN

Financial Performance

In 2024, Cann Group's revenue was 18.36 million, a decrease of -11.03% compared to the previous year's 20.63 million. Losses were -51.24 million, 51.6% more than in 2023.